Donor cell myelodysplastic syndrome afte
✍
Rami Komrokji; Jainulabdeen J. Ifthikharuddin; Raymond E. Felgar; Camille N. Abb
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 172 KB
👁 1 views
## Abstract Allogeneic hematopoietic stem cell transplantation (SCT) is a potentially curative treatment for patients with myelodysplastic syndrome (MDS). Relapses after transplantation however, are not uncommon and are usually due to re‐emergence of a recipient derived, neoplastic, stem cell clone